Two different mutations were found in two unrelated probands with lethal chondrodysplasias, one with achondrogenesis type II and the other with the less severe phenotype of hypochondrogenesis. The mutations in the COL2AJ gene were identified by denaturing gradient gel electrophoresis analysis of genomic DNA followed by dideoxynucleotide sequencing and restriction site analysis. The proband with achondrogenesis type II had a heterozygous single-base mutation that substituted aspartate for glycine at position 310 of the al(II) chain of type II procollagen. The proband with hypochondrogenesis had a heterozygous single-base mutation that substituted serine for glycine at position 805. Type II collagen extracted from cartilage from the probands demonstrated the presence of type I collagen and a delayed electrophoretic mobility, indicating post-translational overmodifications. Analysis of CNBr peptides showed that, in proband 1, the entire peptides were overmodified. [7, 9, 13] .
INTRODUCTION
Hypochondrogenesis is a lethal chondrodysplasia that appears to represent a mild form of achondrogenesis type II [1, 2] . However, there may well be phenotypic overlap between these chondrodysplasias and the non-lethal chondrodysplasia spondyloepiphyseal dysplasia congenita, since a continuous gradient of severity was seen in affected individuals, thus supporting the concept of a chondrodysplasia family [3] . The hypothesis that these chondrodysplasias are closely related is substantiated by the recent demonstrations that heterozygous mutations in the COL2AJ gene for type II collagen are found in probands with all three phenotypes [4] [5] [6] [7] [8] [9] [10] [11] . With most chondrodysplasias it has been difficult to establish the relationship between the genetic defect and the clinical phenotype because cartilage is not available from many probands, and chondrocytes are difficult to maintain in culture without dedifferentiation [12] . New techniques for culturing chondrocytes in three-dimensional systems, however, have been useful to either maintain the chondrocyte phenotype or restore the phenotype after increasing the cell number [7, 9, 13] .
indicated that there was a delayed secretion oftype II procollagen. In addition, type II collagen synthesized by cartilage fragments from the probands demonstrated a decreased thermal stability. The melting temperature of the type II collagen containing the aspartate-for-glycine substitution was reduced by 4°C, and that of the collagen containing the serine-for-glycine substitution was reduced by 2 'C. Electron microscopy of the extracellular matrix from the chondrocyte cultures showed a decreased density of matrix and the presence of unusually short and thin fibrils. Our results indicate that glycine substitutions in the N-terminal region of the type II collagen molecule can produce more severe phenotypes than mutations in the C-terminal region. The aspartate-for-glycine substitution at position 310, which was associated with defective secretion and a probable increased degradation of collagen, is the most destabilizing mutation yet reported in type II procollagen.
Here we have identified a mutation in the COL2AJ gene in one proband with hypochondrogenesis and in another proband with achondrogenesis type II. In addition, by using explant and chondrocyte cultures we have analysed the consequences of the mutations on the function of the protein and the morphology of the tissues.
MATERIALS AND METHODS Case reports
Severe dwarfism was detected by ultrasound examination of the two fetuses at 33 and 35 weeks of gestation. Clinical and radiological examinations of proband 1, who died at birth, were consistent with the diagnosis of hypochondrogenesis, whereas proband 2 was diagnosed as having achondrogenesis type II fetal calf serum (FCS) and 50 ,ug/ml ascorbic acid for 4 h at 37 'C. This medium was replaced by 2 ml of incubation medium depleted in FCS but containing ascorbic acid, amino propionitrile (f8APN) (50 ,g/ml each) and [14C]proline (10 l Ci/ml). The medium was replaced after 48 h and the incubation was continued for 2 days. Cartilage fragments and pooled media were harvested and treated separately. For chondrocyte cultures, cells were released by sequential enzymic digestion with 0.05 % hyaluronidase (Sigma), 0.01 % trypsin and 0.1 % bacterial collagenase (Boehringer Mannheim) as described previously [16] . Cells were washed in DMEM supplemented with 10% FCS, 500 units/ml penicillin and 200 1ug/ml streptomycin. The cells were then seeded in the same medium at a density of 2.5 x 104 cells/cm2 in plastic flasks. They were either trypsin-treated and passaged once or twice, or used directly for redifferentiation in agarose or in alginate beads. For growth in agarose, chondrocytes were resuspended at a density of 4 x 106 cells/ml in 0.4% low-melting agarose and grown for [12] [13] [14] [15] days in DMEM containing 10% FCS [12] . Cultures in alginate beads followed the conditions described by Hauselman et al. [17] . After trypsinization, chondrocytes were (10 ,uCi/ml) in 10 ml of serum-free DMEM supplemented with ascorbic acid and fiAPN (50 ,tg/ml). The culture medium was collected, and the alginate beads or agarose were washed with 5 ml of saline solution which was then added to the culture medium. Collagenous proteins secreted into the medium were precipitated by ammonium sulphate (180 mg/ml) followed by pepsin digestion for 2 h at room temperature in 0.5 M acetic acid. Agarose was scraped and resuspended in saline solution, then homogenized with a Polytron and centrifuged at 30000 g for 1 h. The pellet was resuspended in 0.5 M acetic acid and submitted to pepsin digestion.
The alginate beads were disrupted by treatment for 10 min with 50 mM EDTA until complete dissolution. The cells were pelleted at 1200 rev./min (800 g) for O min and washed twice with 0.15 M NaCl supplemented with proteinase inhibitors. Cells were lysed with 0.1 0% Nonidet P40 in 50 mM Tris/HCl, pH 7.5.
The cell lysate was treated with pepsin to prepare collagen chains corresponding to the intracellular and pericellular fractions. To examine collagen synthesis and secretion, 5 x 101 cells were cultured for 20 days and labelled with 200 ,uCi ofL-[4,5-3H]proline (30 Ci/mmol) for 24 h. In alginate, three different fractions were harvested separately: the culture medium, the cell pellet and the alginate/EDTA mixture (supernatant). In agarose, collagen synthesis was measured in the culture medium and the cell/ agarose fraction. Samples were dialysed extensively against acetic acid solution, followed by hydrolysis with 6 M HCl at 110 'C for 24 h. Tritiated hydroxyproline was separated from proline by passage through an ion-exchange resin as described previously [18] .
Quantification of collagen in cartilage
Total collagen content in cartilage hydrolysates was estimated by the colorimetric determination of hydroxyproline amount according to the method of Stegemann [19] . Results were expressed as mg of collagen per g of dry cartilage.
Electrophoresis of collagen chains and CNBr peptides Neutral-salt-and pepsin-soluble collagens isolated from cartilage or cultured chondrocytes were electrophoresed on 50% polyacrylamide gels using the discontinuous buffer system of Neville and Glossman [20] . Gels were successively stained with Coomassie Blue and processed for fluorography. For (Figure 4) . In exon 42 the base substitution obliterated an HpaII restriction site. This property was used to confirm the heterozygosity of the mutation. The mutation was not detectable in the parental leukocytes ( Figure  3b ), suggesting that it was sporadic.
Quantifcation of collagen in cartilage The collagen content of cartilage samples from both probands and controls were measured. Proband 2 presented a dramatic reduction in collagen content (94 mg/g of dry cartilage versus 325 + 50 mg/g for controls; n = 7), whereas proband 1 was not significantly different from control (280 mg/g).
Resident collagens
Collagens extracted sequentially in neutral salt buffer and after pepsin digestion were analysed by gel electrophoresis. In the neutral-salt collagen fraction, an al(II) chain with normal mobility was predominant. In addition, in both probands a faint band with a delayed mobility was detectable (Figure 5a ). In the pepsin-soluble collagen fraction a broad band corresponding to the juxtaposition of two components was observed (Figure 5b Electrophoretic studies of collagens
The cartilage explant system was used to analyse simultaneously the resident collagens of cartilage and the newly synthesized molecules ('4C-labelled). pepsin-soluble collagen (0.8 M NaCl fraction) were run on a 12 % polyacrylamide gel. In material from proband 1, peptides CBI0.5, CB8 and CB9.7 had a delayed mobility when compared with the control (Figure 6a ), suggesting that overmodifications extended beyond the mutation. The presence of an additional peptide which co-migrated with al(I) CB6 confirmed that both type I and II collagens were present. Peptides al(I) CB8 and CB7 are likely to co-migrate with the al(II) CB1 1 normal and overmodified peptides respectively (Figure 6a ). In material from proband 2, the presence of acl(I) CB peptides was also detected, but the mobility of peptides al(II) CB10.5, CB8 and CB9.7 was not clearly different from the control (Figure 6b ).
In vitro collagen synthesis Newly synthesized collagens in cartilage fragments cultured in DMEM in the presence of [14C]proline were detected mainly in the salt-soluble fraction isolated from the labelled tissue. A small amount of material was secreted into the culture medium. Under reducing conditions, three major bands were detected in the medium. The most intense band corresponded to the acl(II) chain and the two minor upper bands represented procollagen proa I (II) and the partially processed chains p.al(II). All these bands in cartilage from the probands had a delayed mobility when compared with control cartilage (Figure 7, lanes 3-8) . When the neutral-salt-soluble fraction was pepsin-digested, type XI collagen chains became detectable; their electrophoretic mobilities were normal (Figure 7, lanes 9 and 10) . However, no a2(I) chain was visible. Type II collagen migrated as a broad band with a delayed mobility. The normal al(II) collagen, which corresponded to the lower part of the band, was less abundant than the upper part [overmodified oal(II) chains]. These results, which strictly differed from those obtained with the resident material, indicated that most of the newly synthesized cl(II) homotrimers contained at least one mutant monomer. They also suggested that part of the abnormal type II collagen, instead of being incorporated into resident collagen, was degraded.
Collagen synthesis by chondrocytes cultured In agarose or in alginate Chondrocytes were first grown in monolayers in order to increase their number, then transferred to agarose or alginate beads and cultured for at least 10 days to induce the re-expression of cartilage-specific collagens (types II and XI). As al1(11) chain synthesized by chondrocytes from proband 2 cultured in agarose migrated more slowly than that from control chondrocytes ( Figure 7, lanes 11 and 12) . In alginate beads, the amount of collagen synthesized by chondrocytes was measured in the culture medium, the alginate suspension and the isolated cells, since it was possible to separate cells from the loose matrix present between adjacent cells. In the agarose system, only the culture medium and the agarose-cell mixture were recoverable separately. The [3H]hydroxyproline content was measured in order to evaluate total collagen synthesis. Although variations existed between the different fractions, the total amount of hydroxyproline in proband chondrocytes was markedly reduced (by approx. 50%) when compared with normal chondrocytes (Table 2) . In proband 2, the collagen type II/type XI ratio was decreased by about 65 % ( Table 2 ), suggesting that the mutation affected mostly type II collagen secretion.
Thermal stability
The thermal denaturation temperature (Tm) of the triple helix of pepsin-digested collagen extracted from cartilage was measured to evaluate the stability of normal and mutant al(II) chains. Cartilage fragments were incubated with ['4C]proline and the thermal stability was assayed by brief proteinase digestion [21] . developed rough endoplasmic reticulum (RER) and an abundant Golgi system (Figures 9a and 9b) . However, in contrast to previous in situ studies, there was no evidence of large vacuoles of dilated RER in proband chondrocytes (see [11, 22] ). A marked decrease in the extracellular matrix density was observed. Although variability existed between different fields, most of the collagen fibrils in both probands looked less abundant and shorter than in control cells (Figures 10a-lOc) . These observations were consistent with the decreased collagen secretion by proband chondrocytes.
DISCUSSION
We have identified a single-base heterozygous mutation in the COL2AJ gene in one proband with hypochondrogenesis, and another single-base heterozygous mutation in the same gene in another proband with achondrogenesis type II. One mutation substituted a serine codon for a glycine codon, and the other an aspartic acid codon for a glycine codon. Since the collagen triple helix folds in a C-to N-terminal direction, it has been suggested that mutations in the C-terminal domains are more likely to produce severe phenotypes than mutations in the N-terminal domains (see [23] ). The results here are inconsistent with this general conclusion, since the substitution of aspartic acid for glycine-310 produced a more severe phenotype than the substitution of serine for glycine-805. To the best of our knowledge, the substitution of glycine-310 is the most N-terminal amino acid substitution reported in achondro-hypochondrogenesis [4, 6, 7, 10, 11] . In contrast, most reported mutations in the Nterminal domain of the type II collagen triple helix were found in non-lethal chondrodysplasias such as spondylo-epimetaphyseal dysplasia [24] , Kniest dysplasia [25] and Wagner-Stickler syndrome [26] . The more severe phenotype seen here may be explained by the nature of the amino acid substitution, since all aspartate-for-glycine substitutions in the COLIAJ and COLIA2 genes produce lethal osteogenesis imperfecta [23, 27] . It is also possible, however, that the specific sequence at the aspartate-toglycine substitution is critical, since the mutation changed the normal sequence Glu-Arg-Gly to Glu-Arg-Asp. The presence of a second negatively charged residue in the sequence may well destabilize the triple helix since, as suggested by Katz and David [28] , intrachain salt linkage formation may contribute to the normal stability of the collagen triple helix. The substitution ofaspartate for glycine-3 10 markedly reduced the stability of the triple helix, as assayed by brief proteinase digestion. The presence of aspartate may well have caused local unfolding of the triple helix, making the adjacent arginine susceptible to trypsin digestion. The marked destabilization of the triple helix caused by the aspartate-for-glycine substitution, however, is somewhat surprising, since reductions in thermal stability were not seen in recombinant type II procollagen with an internal deletion of 12 exons covering much of the same region of the molecule [29] . Also, no reduction in thermal stability was seen with substitutions in the coding sequences of type II procollagen in achondro-hypochondrogenesis or spondyloepiphyseal dysplasia [9, 11, 30] . The aspartate-for-glycine substitution at position 310 appears to be the most destabilizing mutation reported to date in the type II collagen molecule.
Tissue culture and three-dimensional cultures of chondrocytes were initiated in order to examine the consequences of the mutations on the elaboration of the matrix. Quantification of collagen synthesis indicated that the present substitutions lead to inefficient type II collagen secretion, a result that was supported by electron microscopic examination of the matrix surrounding cultured chondrocytes. In agreement with previous results using chondrocytes on agarose [7] , the number of collagen fibrils relative to proteoglycan granules was apparently reduced. Unexpectedly, dilated vacuoles of RER were not seen. The discrepancy between these results and in situ findings [11, 22] is not clearly understood, but might be related to the in vitro culture system itself and/or to a rapid degradation of unstable molecules without intracellular retention. Indirect evidence for increased degradation is provided by the observation that the amount of total resident collagen that was extractable from proband 2 829 cartilage was reduced by 70 % when compared with the control, whereas the amount of labelled collagen synthesized by chondrocytes in culture was decreased by only 50%. In addition, the difference between the amount of resident collagen which was rich in normal a l(II) chains and the newly synthesized material, which contained mostly abnormal chains, supports the hypothesis that a proportion of the abnormal chains were not incorporated into stable fibrils but were rapidly degraded.
Type I collagen is normally absent from control cartilage, but it was previously reported to replace completely type II collagen in two patients with achondrogenesis II [31, 32] . The situation was different in our proband 2. Type I collagen is likely to originate from the numerous infiltrating vascular canals, since it was detected at significant levels in the resident collagen but was not synthesized in organ culture. Therefore, in our case, type I collagen did not appear to be the major component of cartilage. Its amount was in the same range in proband 2 as in proband 1, suggesting that there is no strict correlation between the abundance of type I collagen in achondro-hypochondrogenesis and the clinical severity of the disease.
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